#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hodgkin's disease Hereditary hypophosphataemic rickets T-cell lymphoma B-cell lymphoma refractory Haemophilia A without inhibitors C3 glomerulopathy Pulmonary fibrosis Leukoencephalopathy Aplastic anaemia Granulomatosis with polyangiitis Congenital hypotransferrinaemia Haemolytic uraemic syndrome Fms-like tyrosine kinase 3 positive Anaplastic large cell lymphoma T- and null-cell types Hairy cell leukaemia recurrent More trials…

    Learn about Rare Diseases

    Primary immunodeficiency syndrome – Basic Information Ewing’s sarcoma metastatic – Basic Information Pulmonary fibrosis – Treatment Noonan syndrome – Diagnostics Focal segmental glomerulosclerosis – Diagnostics Hairy cell leukaemia recurrent – Basic Information Toxic epidermal necrolysis – Treatment Breast angiosarcoma metastatic – Treatment Alternating hemiplegia of childhood – Basic Information Castleman’s disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Atrasentan Hydrochloride Mk-1200 Tremelimumab Dsimc DROSPIRENONE Wt1 Lamp Mrna Dc Carcik-Cd19 Cells Copanlisib Dihydrochloride Tetrahydrouridine Dornase Alfa MAGNESIUM CARBONATE HEAVY Sulfonamides, Urea Derivatives Xxb750 Busulfan Lt3001 Agomelatine Sebetralstat AZD0516 Aminohippuric Acid Zoledronic Acid Monohydrate More therapies…

    Learn about Your Condition

    Acquired haemophilia Inborn error of metabolism Laryngeal cancer Cardiac disorder Tooth loss Pulmonary venous thrombosis Mitral valve disease Essential hypertension Myasthenia gravis Pleomorphic liposarcoma Gout Lichen sclerosus Mucopolysaccharidosis II Genital herpes Vasospasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Male Urogenital Diseases

  • Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End Stage Kidney Disease on Hemodialysis

    Not recruiting

    3 1
    Investigated Diseases:
    • Hyperparathyroidism secondary
    Investigated Drugs:
    • Upacicalcet Sodium Hydrate
    Bulgaria Poland Portugal Spain

  • Study of Cefazolin for Patients on Chronic Hemodialysis with Infections

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Device related infection
    • Haemodialysis
    Investigated Drugs:
    • Cefazolin
    France

  • Study on the Effectiveness and Safety of RO7434656 for Patients with Primary IgA Nephropathy at High Risk of Progression

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Isis 696844
    Czechia France Germany Greece Italy Poland +1

  • Study on the Effectiveness and Safety of Follitropin Delta for Men with Unexplained Infertility

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Infertility male
    Investigated Drugs:
    • Follitropin Delta
    Belgium Denmark Germany Italy Spain Sweden

  • Study on Ilofotase Alfa to Prevent Kidney Damage in Patients Undergoing Open Heart Surgery

    Not recruiting

    2 1
    Investigated Diseases:
    • Renal injury
    Investigated Drugs:
    • Ilofotase Alfa
    Belgium Germany The Netherlands

  • Study on Denosumab for Improving Semen Quality in Men with Infertility

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Infertility male
    Investigated Drugs:
    • Saline
    • Denosumab
    Denmark
Previous Page
1 … 20 21 22 23 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!